Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization

2025/12/01 by Awais Ali · 1 voice
Biochemistry, Genetics and Molecular Biology · Engineering · Immunology and Microbiology · #Immunotherapy and Immune Responses #Nanoplatforms for cancer theranostics #RNA Interference and Gene Delivery

paper · doi:10.1007/s11596-025-00127-y

crossref issued 2025/12/01 · crossref published 2025/12/01 · crossref published-print 2025/12/01 · openalex publication_date 2025/12/01 · crossref published-online 2025/12/08 · openalex created_date 2025/12/08 · crossref created 2025/12/08 · crossref deposited 2025/12/29 · crossref indexed 2025/12/29 · openalex updated_date 2026/07/23

Citations

• An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
• Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
• Lipid nanoparticles for mRNA delivery
• Hepatitis B Vaccines
• Cancer vaccines: the next immunotherapy frontier

Discussions

• This review explores delivery strategies for #mRNA #CancerVaccines, addressing technical challenges and #BiologicalMechanisms, while highlighting breakthroughs that accelerate #ImmuneBased treatments. [bsky, 0 points, 0 comments]